You are here: Accueil Domaines Juridiques Propriété intellectuelle
Envoyé: 20 April 2017
The UK general election on 08 June 2017 may delay the UK's ratification of the UPC Agreement but it is not expected to delay the launch of the Unified Patent Court by more than a month or so.
Envoyé: 19 April 2017
Both licensors and licensees may wish to consider the inclusion of arbitration provisions in renegotiation clauses of long-term licensing arrangements following the recent judgment in Associated British Ports v Tata Steel UK Limited.
Envoyé: 12 April 2017
The Cyberspace Administration of China issued a draft measures for public consultation, which expands the application of the security assessment requirement for exporting data outside of China. These measures, if adopted, would have impact on a number of business involving cross-border transfers.
Date de l’évènement: 18 May 2017
Our 10th annual TMT Sector Update offers you the chance to hear about a broad range of current commercial and legal topics from key players in the TMT sector.
Envoyé: 30 March 2017
The UK has given notice to cease to be one of the Member States of the European Union (EU) (Brexit) - what does this mean in practice?
Envoyé: 15 March 2017
Envoyé: 28 February 2017
On 15 February 2017, the European Commission published an Inception Impact Assessment to evaluate options for optimising the legal framework concerning Supplementary Protection Certificates (SPCs) and patent research exemptions for sectors whose products are subject to regulated market authorisations.
Envoyé: 27 February 2017
Following the adoption by MedTech Europe of a revised version of the MedTech Europe Code in late 2015, the ABHI has begun to implement it through the ABHI Code from 01 January 2017.
Envoyé: 14 February 2017
The Beijing IP Court recently issued its decision in a cancellation action on the grounds of non-use and also
overrules the decision of the Trademark Review and Adjudication Board to maintain the registration
of the subject mark, the court for the first time sanctioned the owners of the trademark for submitting
falsified evidence in an attempt to deceive the court.
Envoyé: 26 January 2017
The Court of Appeal has upheld the decision that Genentech’s patent for Herceptin, administered together with a taxane, is invalid for obviousness.
Podcast 571: Bad faith in trademark applications in China
Afficher tous les podcasts vidéos
Londres 18 May 2017
Afficher tous les événements
Voir tous les supports de formation
© Simmons & Simmons LLP 2017. All rights reserved. Registered in England & Wales Registered Number OC352713
elexica Limited, CityPoint, One Ropemaker Street, London EC2Y 9SS T: +44 20 7628 2020